Authors:
Lehtimaki, L
Kankaanranta, H
Saarelainen, S
Hahtola, P
Jarvenpaa, R
Koivula, T
Turjanmaa, V
Moilanen, E
Citation: L. Lehtimaki et al., Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation, AM J R CRIT, 163(7), 2001, pp. 1557-1561
Authors:
Lehtimaki, L
Kankaanranta, H
Saarelainen, S
Turjanmaa, V
Moilanen, E
Citation: L. Lehtimaki et al., Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma, EUR RESP J, 18(4), 2001, pp. 635-639
Authors:
Saarelainen, S
Lehtimaki, T
Nikkila, M
Solakivi, T
Nieminen, MM
Jaakkola, O
Citation: S. Saarelainen et al., Association between apolipoprotein E alleles and autoantibodies against oxidised low-density lipoprotein, CLIN CH L M, 38(5), 2000, pp. 477-478
Authors:
Lehtimaki, L
Turjanmaa, V
Kankaanranta, H
Saarelainen, S
Hahtola, P
Moilanen, E
Citation: L. Lehtimaki et al., Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates, ANN MED, 32(6), 2000, pp. 417-423
Authors:
Saarelainen, S
Lehtimaki, T
Jaakkola, O
Poussa, T
Nikkila, M
Solakivi, T
Nieminen, MM
Citation: S. Saarelainen et al., Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea, CLIN CH L M, 37(5), 1999, pp. 517-520
Authors:
Westbroek, J
Saarelainen, S
Laher, M
O'Brien, J
Barnacle, H
Efthimiou, J
Citation: J. Westbroek et al., Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma, RESP MED, 93(10), 1999, pp. 689-699